MEREO BIOPHARMA GROUP PLC Minimum Lease Payments Payable Under Noncancellable Operating Lease
MEREO BIOPHARMA GROUP PLC (MREO) had Minimum Lease Payments Payable Under Noncancellable Operating Lease of GBP 535.66 thousand as of 2018-12-31, per its 20-F/A filed 2019-05-29.
Discontinued › Notes › Leases
ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease · last filed 2019-05-29
- 2018-12-31: Minimum Lease Payments Payable Under Noncancellable Operating Lease 535.66K GBP.
- 2017-12-31: Minimum Lease Payments Payable Under Noncancellable Operating Lease 1.28M GBP.
| Period end | Minimum Lease Payments Payable Under Noncancellable Operating Lease |
|---|---|
| 2018-12-31 | 535.66K GBP 20-F/A · filed 2019-05-29 |
| 2017-12-31 | 1.28M GBP 20-F/A · filed 2019-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |